Benzhydramine hydrochloride; 2-(Benzhydryloxy)-N,N-dimethylethylamine hydrochloride; N-(2-Diphenylmethoxyethyl)-N,N-dimethylamine hydrochloride

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

Virtual Booth

Contact Supplier

Access all COS suppliers
Check all USDMF suppliers

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 16 USDMF, 4 CEP/COS, 1 JDMF, 5 EU WC, 2 KDMF, 18 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

301 FDF Dossiers, 118 FDA Orange Book, 4 Europe, 94 Canada, 47 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT, INJECTABLE;INJECTION - 50MG/ML, ELIXIR;ORAL - 12.5MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Evonik, 11 Rochem International Inc, 22 SPI Pharma, 29 DKSH, 2 Pharm-RX Chemical, 11 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 21 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 24 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 54 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 4 CD Formulation, 4 Clariant, 17 Corel Pharma Chem, 7 DFE Pharma, 3 Esteem Industries, 4 Finar, 19 Gangwal Chemicals, 2 Huzhou Sunflower Pharmaceutical, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 24 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 43 Roquette, 25 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 4 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

109 Fillers, Diluents & Binders, 81 Topical, 77 Coating Systems & Additives, 72 Thickeners and Stabilizers, 69 Solubilizers, 54 Direct Compression, 48 Taste Masking, 45 Disintegrants & Superdisintegrants, 44 Granulation, 43 Controlled & Modified Release, 41 Parenteral, 33 Film Formers & Plasticizers, 29 Emulsifying Agents, 25 Chewable & Orodispersible Aids, 24 Lubricants & Glidants, 22 Rheology Modifiers, 16 Co-Processed Excipients, 15 Surfactant & Foaming Agents, 11 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

18 News #PharmaBuzz

18 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

44 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

Xls

Filters

Company Name

Year

DEALS // DEV.

Country

Sponsor

Therapeutic Area

Study Phase

Deal Type

Product Type

Dosage Form

Lead Product

Target

Filters

Reset Filter

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Granules India Limited

India

CPhI WW Frankfurt

Booth #H9.1A48

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Lead Product(s) : Naproxen Sodium,Diphenhydramine Hydrochloride

Therapeutic Area : Neurology

Study Phase : Approved FDF

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

DEALS_DEV

Granules India Receives FDA Approval for Naproxen Sodium/Diphenhydramine Tablets

Details : Generic of Naproxen Sodium and Diphenhydramine HCl Tablets are approved for relief of occasional sleeplessness associated with minor aches and pains and to help you fall asleep and stay asleep.

Product Name : Aleve-Generic

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

September 25, 2020

Lead Product(s) : Naproxen Sodium,Diphenhydramine Hydrochloride

Therapeutic Area : Neurology

Highest Development Status : Approved FDF

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Virtual Booth

02

Overseas Pharma

India

U.S.A

EPSC

Not Confirmed

Find Clinical Drug Pipeline Developments & Deals for Benzhydramine hydrochloride; 2-(Benzhydryloxy)-N,N-dimethylethylamine hydrochloride; N-(2-Diphenylmethoxyethyl)-N,N-dimethylamine hydrochloride